WealthTrust Fairport LLC boosted its holdings in shares of Johnson & Johnson (NYSE:JNJ) by 23.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 21,385 shares of the company’s stock after buying an additional 4,031 shares during the quarter. WealthTrust Fairport LLC’s holdings in Johnson & Johnson were worth $2,595,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also made changes to their positions in the business. Financial Gravity Wealth Inc. bought a new stake in shares of Johnson & Johnson during the first quarter worth approximately $105,000. WP Advisors LLC bought a new stake in shares of Johnson & Johnson during the second quarter worth approximately $108,000. FNY Investment Advisers LLC bought a new stake in shares of Johnson & Johnson during the second quarter worth approximately $117,000. Fusion Family Wealth LLC boosted its holdings in shares of Johnson & Johnson by 621.4% during the second quarter. Fusion Family Wealth LLC now owns 1,010 shares of the company’s stock worth $123,000 after acquiring an additional 870 shares during the period. Finally, Live Your Vision LLC boosted its holdings in shares of Johnson & Johnson by 58.3% during the second quarter. Live Your Vision LLC now owns 1,363 shares of the company’s stock worth $172,000 after acquiring an additional 502 shares during the period. 66.45% of the stock is currently owned by hedge funds and other institutional investors.
Several equities research analysts recently issued reports on JNJ shares. Zacks Investment Research upgraded Johnson & Johnson from a “hold” rating to a “buy” rating and set a $165.00 price target for the company in a research note on Tuesday, November 20th. HC Wainwright reiterated a “buy” rating on shares of Johnson & Johnson in a research note on Wednesday, October 17th. Credit Suisse Group set a $149.00 target price on Johnson & Johnson and gave the stock a “buy” rating in a research note on Sunday, October 14th. ValuEngine upgraded Johnson & Johnson from a “hold” rating to a “buy” rating in a research note on Thursday. Finally, Citigroup upped their target price on Johnson & Johnson from $137.00 to $148.00 and gave the stock a “neutral” rating in a research note on Monday, October 22nd. Two equities research analysts have rated the stock with a sell rating, six have given a hold rating and ten have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $142.58.
Johnson & Johnson (NYSE:JNJ) last announced its quarterly earnings results on Tuesday, October 16th. The company reported $2.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.03 by $0.02. The company had revenue of $20.35 billion during the quarter, compared to the consensus estimate of $20.05 billion. Johnson & Johnson had a net margin of 1.89% and a return on equity of 34.62%. The company’s revenue for the quarter was up 3.6% compared to the same quarter last year. During the same period in the prior year, the business earned $1.90 earnings per share. On average, sell-side analysts anticipate that Johnson & Johnson will post 8.16 EPS for the current year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, December 11th. Stockholders of record on Tuesday, November 27th were issued a dividend of $0.90 per share. The ex-dividend date of this dividend was Monday, November 26th. This represents a $3.60 annualized dividend and a dividend yield of 2.71%. Johnson & Johnson’s dividend payout ratio (DPR) is presently 49.32%.
In other news, CEO Alex Gorsky sold 264,465 shares of the company’s stock in a transaction on Friday, November 16th. The shares were sold at an average price of $145.96, for a total transaction of $38,601,311.40. Following the completion of the transaction, the chief executive officer now directly owns 481,254 shares in the company, valued at $70,243,833.84. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Joaquin Duato sold 40,000 shares of the company’s stock in a transaction on Wednesday, November 7th. The stock was sold at an average price of $144.36, for a total transaction of $5,774,400.00. Following the transaction, the insider now owns 112,848 shares of the company’s stock, valued at $16,290,737.28. The disclosure for this sale can be found here. Insiders have sold 514,187 shares of company stock valued at $74,951,528 over the last quarter. Company insiders own 0.22% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Johnson & Johnson (JNJ) Holdings Boosted by WealthTrust Fairport LLC” was originally published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this story on another website, it was illegally copied and republished in violation of United States & international trademark & copyright legislation. The correct version of this story can be accessed at https://www.com-unik.info/2018/12/16/johnson-johnson-jnj-holdings-boosted-by-wealthtrust-fairport-llc.html.
Johnson & Johnson Profile
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women’s health, and wound care markets.
Further Reading: Return on Investment (ROI) Defined, Explained
Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).
Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.